Latest Breaking News On - கிஸ்ல் பெஹ்ரிங் - Page 3 : comparemela.com

CoVIg-19 Plasma Alliance Saturday, April 3, 2021 2:00PM IST (8:30AM GMT)   Osaka, Japan & King of Prussia, Pa., United States:    Phase 3 Inpatient Treatment With Anti-Coronavirus Immunoglobulin (ITAC) Clinical Trial Sponsored and Funded by the National Institute of Allergy and Infectious Diseases (NIAID), Part of the National Institutes of Health (NIH), Did Not Meet Its Endpoints to Show Efficacy in Adults Hospitalized With COVID-19 The CoVIg-19 Plasma Alliance today announced that the Phase 3 Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC) clinical trial sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), did not meet its endpoints. No serious safety signals were raised in the trial.

United statesJulie kimPlasma allianceHead of researchNational institutes of healthNational institute of allergyMelinda gates foundationNational bioproducts institutePart of the national institutes healthUber healthAlliance as covigTreatment with anti coronavirus immunoglobulinClinical trial sponsoredNational instituteInfectious diseasesNational institutes